Pages that link to "Q34101831"

The following pages link to Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia (Q34101831):

Displaying 45 items.

• Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. (Q30493972) (← links)
• Communicating the results of clinical research to participants: attitudes, practices, and future directions (Q33334605) (← links)
• Clinical genetics of Alzheimer's disease (Q33737786) (← links)
• Why should primary care physicians know about the genetics of dementia? (Q34115616) (← links)
• Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions (Q34135724) (← links)
• The role of tau (MAPT) in frontotemporal dementia and related tauopathies (Q34348115) (← links)
• Attitudes regarding predictive testing for retinitis pigmentosa (Q34622242) (← links)
• Schizophrenia and genetics: new insights (Q34749234) (← links)
• Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease (Q35029086) (← links)
• Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics (Q35316963) (← links)
• Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials (Q35400583) (← links)
• Familial Frontotemporal Dementia: From Gene Discovery to Clinical Molecular Diagnostics (Q35538685) (← links)
• Differences Between African American and White Research Volunteers in Their Attitudes, Beliefs and Knowledge Regarding Genetic Testing for Alzheimer's Disease (Q35570857) (← links)
• Genetics and genetic counseling: recommendations for Alzheimer's disease, frontotemporal dementia, and Creutzfeldt-Jakob disease (Q35868590) (← links)
• A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease (Q35879102) (← links)
• Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors (Q35889850) (← links)
• New approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degeneration (Q36218610) (← links)
• Suicide and assisted dying in dementia: what we know and what we need to know. A narrative literature review (Q36360331) (← links)
• Genetics and dementia nosology (Q36552904) (← links)
• Genetic research and genetic testing in Alzheimer's disease: a view from the bridge (Q36833988) (← links)
• Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit (Q36885357) (← links)
• Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease (Q37029649) (← links)
• Genetic aspects of Alzheimer disease (Q37139063) (← links)
• A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases (Q37323166) (← links)
• Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges (Q37352376) (← links)
• The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease. (Q37380826) (← links)
• Dementia and suicidal behavior: a review of the literature (Q37445171) (← links)
• Genetic Counseling for Frontotemporal Dementias (Q37879976) (← links)
• Early-onset familial Alzheimer's disease (EOFAD). (Q38021307) (← links)
• Genetics of dementia: update and guidelines for the clinician (Q38027808) (← links)
• Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues (Q38219529) (← links)
• Psychological Impact of Predictive Genetic Testing in VCP Inclusion Body Myopathy, Paget Disease of Bone and Frontotemporal Dementia (Q39035327) (← links)
• Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations. (Q39354046) (← links)
• Emotional reactions to predictive testing in Alzheimer's disease and other inherited dementias (Q40392327) (← links)
• To test or not to test: interest in genetic testing for Alzheimer's disease among middle-aged adults (Q40602800) (← links)
• The Effect of Predictive Testing in Adult-Onset Neurodegenerative Diseases on Social and Personal Life (Q47570840) (← links)
• Completed suicide in an autopsy-confirmed case of early onset Alzheimer's disease. (Q47659519) (← links)
• Overall and domain-specific life satisfaction when living with familial Alzheimer's disease risk: A quantitative approach (Q47754247) (← links)
• Ethical considerations in the presymptomatic diagnosis of Alzheimer's disease (Q53324499) (← links)
• Revised NIA-AA criteria for the diagnosis of Alzheimer's disease: a step forward but not yet ready for widespread clinical use. (Q53427571) (← links)
• [Neurodegenerative diseases]. (Q53512466) (← links)
• Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series (Q57048525) (← links)
• One Size Does Not Fit All (Q57988438) (← links)
• Genetics of dementia (Q74595917) (← links)
• Physician and patient determinants of prognostic counseling in idiopathic REM sleep-behavior disorder (Q90457376) (← links)